Cellular Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.6 | Q1 | 95.6% | 1.561 | Q1 | 92.6% |
| 2024 | 4.8 | Q1 | 92.2% | 1.573 | Q1 | 92.8% |
| 2023 | 4.9 | Q1 | 87.2% | 1.489 | Q1 | 92.6% |
| 2022 | 6.6 | Q1 | 90.9% | 1.408 | Q1 | 92.3% |
| 2021 | 7.1 | Q1 | 89.5% | 1.326 | Q1 | 91.5% |
| 2020 | — | — | 1.698 | Q1 | 93.9% | |
| 2019 | — | — | 1.271 | Q1 | 90.2% | |
| 2018 | — | — | 1.457 | Q1 | 91.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2211-3428
ISSN
2211-3436
country
coverage
2011-2026
